Log In
BCIQ
Print this Print this
 

Staphylococcus lysin (CF-301)

  Manage Alerts
Collapse Summary General Information
Company ContraFect Corp.
DescriptionStaphylococcal-specific lysin protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/03/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today